Applying Behavioral Economics Theories to Interventions for Persons with Diabetes.

IF 5.2 2区医学 Q1 ENDOCRINOLOGY & METABOLISM Current Diabetes Reports Pub Date : 2022-05-01 Epub Date: 2022-03-10 DOI:10.1007/s11892-022-01460-5

Susana R Patton, Christopher C Cushing, Amy Hughes Lansing

{"title":"Applying Behavioral Economics Theories to Interventions for Persons with Diabetes.","authors":"Susana R Patton, Christopher C Cushing, Amy Hughes Lansing","doi":"10.1007/s11892-022-01460-5","DOIUrl":null,"url":null,"abstract":"Purpose of review: To introduce behavioral economics (BE), provide a description of how recent prevention and treatment interventions in persons with diabetes have incorporated BE in their intervention strategies, and discuss how BE could be used to inform new treatments for the clinical setting or research.Recent findings: In most of the trials described, researchers incorporated BE into their design in the form of incentives, which can align with present bias, optimism bias, and loss aversion. With only two exceptions, these trials reported preliminary support for using incentives to promote lifestyle modifications and diabetes-related tasks. Additionally, two trials reported promising results for behavior change strategies informed by default bias, while three trials reported promising results for behavior change strategies informed by social norms. Recent trials incorporating BE in prevention and treatment interventions for persons with diabetes generally report promising results, though gaps exist for research and clinical deployment.","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"22 5","pages":"219-226"},"PeriodicalIF":5.2000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951181/pdf/nihms-1868970.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Diabetes Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11892-022-01460-5","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/3/10 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of review: To introduce behavioral economics (BE), provide a description of how recent prevention and treatment interventions in persons with diabetes have incorporated BE in their intervention strategies, and discuss how BE could be used to inform new treatments for the clinical setting or research.

Recent findings: In most of the trials described, researchers incorporated BE into their design in the form of incentives, which can align with present bias, optimism bias, and loss aversion. With only two exceptions, these trials reported preliminary support for using incentives to promote lifestyle modifications and diabetes-related tasks. Additionally, two trials reported promising results for behavior change strategies informed by default bias, while three trials reported promising results for behavior change strategies informed by social norms. Recent trials incorporating BE in prevention and treatment interventions for persons with diabetes generally report promising results, though gaps exist for research and clinical deployment.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

将行为经济学理论应用于对糖尿病患者的干预。

综述目的：介绍行为经济学（BE），说明近期针对糖尿病患者的预防和治疗干预如何将行为经济学纳入干预策略，并讨论如何利用行为经济学为临床或研究提供新的治疗方法：在所描述的大多数试验中，研究人员以激励的形式将 BE 纳入其设计中，这可能与现在偏差、乐观偏差和损失厌恶相一致。只有两项试验例外，这些试验报告初步支持使用激励措施来促进生活方式的改变和糖尿病相关任务的完成。此外，有两项试验报告称，基于默认偏差的行为改变策略取得了可喜的成果，有三项试验报告称，基于社会规范的行为改变策略取得了可喜的成果。最近将 BE 纳入糖尿病患者预防和治疗干预措施的试验普遍报告了良好的结果，但在研究和临床应用方面还存在差距。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Current Diabetes Reports 医学 -

CiteScore

9.80

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： The goal of this journal is to publish cutting-edge reviews on subjects pertinent to all aspects of diabetes epidemiology, pathophysiology, and management. We aim to provide incisive, insightful, and balanced contributions from leading experts in each relevant domain that will be of immediate interest to a wide readership of clinicians, basic scientists, and translational investigators. We accomplish this aim by appointing major authorities to serve as Section Editors in key subject areas across the discipline. Section Editors select topics to be reviewed by leading experts who emphasize recent developments and highlight important papers published over the past year on their topics, in a crisp and readable format. We also provide commentaries from well-known figures in the field, and an Editorial Board of internationally diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research.